2-Chloro-N6-methyl-2’-deoxyadenosine manufacturers
|
| | 2-Chloro-N6-methyl-2’-deoxyadenosine Basic information |
| Product Name: | 2-Chloro-N6-methyl-2’-deoxyadenosine | | Synonyms: | 2-Chloro-N6-methyl-2’-deoxyadenosine;Adenosine, 2-chloro-2'-deoxy-N-methyl-;2,4(1H,3H)-Pyrimidinedione, 5-[5-O-[bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-2-O-(2-methoxyethyl)-β-D-ribofuranosyl]-1-[(phenylmethoxy)methyl]- (ACI) | | CAS: | 146196-08-9 | | MF: | C11H14ClN5O3 | | MW: | 299.71 | | EINECS: | | | Product Categories: | | | Mol File: | 146196-08-9.mol |  |
| | 2-Chloro-N6-methyl-2’-deoxyadenosine Chemical Properties |
| Boiling point | 580.9±60.0 °C(Predicted) | | density | 1.83±0.1 g/cm3(Predicted) | | pka | 13.76±0.60(Predicted) |
| | 2-Chloro-N6-methyl-2’-deoxyadenosine Usage And Synthesis |
| Uses | 2-Chloro-N6-methyl-2’-deoxyadenosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 2-Chloro-N6-methyl-2’-deoxyadenosine Preparation Products And Raw materials |
|